간질 모니터링 기기 시장 예측 : 제품 유형, 유형, 환자층, 유통 채널, 기술, 최종사용자 및 지역별 분석(-2034년)

According to Stratistics MRC, the Global Epilepsy Monitoring Devices Market is accounted for $0.68 billion in 2026 and is expected to reach $1.13 billion by 2034 growing at a CAGR of 6.6% during the forecast period. Epilepsy monitoring devices are specialized medical systems designed to continuously record and analyze neurological activity to detect, diagnose, and manage epileptic seizures. These devices typically capture electroencephalography (EEG) signals, along with complementary physiological parameters such as heart rate, movement, and oxygen levels. They are used in both clinical and home settings to support accurate seizure classification, treatment planning, and long-term disease management. Advanced solutions integrate wearable technology, cloud connectivity, and artificial intelligence to enable real time monitoring, remote data access, and improved patient outcomes through timely clinical intervention and personalized care strategies.

Market Dynamics:

Driver:

Rising adoption of exotic pets

The rising adoption of exotic pets has indirectly contributed to the growth of epilepsy monitoring devices, as awareness of neurological conditions across both human and veterinary domains increases. This trend reflects a broader shift toward advanced diagnostic and monitoring solutions. In human healthcare, growing awareness of epilepsy, coupled with increased demand for continuous monitoring technologies, is driving device adoption. Additionally, technological advancements in wearable and portable EEG systems are enhancing accessibility, encouraging both hospitals and homecare settings to adopt these devices widely.

Restraint:

Strict regulations and import restrictions

Strict regulatory frameworks and import restrictions pose significant challenges to the market. Compliance with stringent approval processes, particularly for medical-grade EEG systems and wearable technologies, increases time-to-market and operational costs for manufacturers. In addition, varying regulatory standards across countries complicate global expansion strategies. Import limitations on sensitive medical equipment further restrict availability in developing regions, limiting patient access. These factors collectively hinder innovation, delay product launches, and create barriers for small and medium sized enterprises entering the market.

Opportunity:

Urbanization and lifestyle shifts

Rapid urbanization and evolving lifestyle patterns present strong growth opportunities for the market. Increasing stress levels, sedentary habits, and changing environmental conditions have contributed to a higher prevalence of neurological disorders, including epilepsy. Urban populations also demonstrate greater awareness and access to advanced healthcare technologies, driving demand for continuous monitoring solutions. Furthermore, improved healthcare infrastructure, rising disposable incomes and expanding telemedicine services in urban areas support the adoption of wearable and home based epilepsy monitoring devices.

Threat:

High cost of ownership and specialized care

The high cost of epilepsy monitoring devices and the need for specialized care present a notable threat to market growth. Advanced monitoring systems, including long-term EEG and AI-integrated devices, involve significant upfront investment and maintenance expenses. Additionally, accurate diagnosis and data interpretation require skilled neurologists and trained professionals, which may not be readily available in all regions. These cost and expertise barriers limit adoption, particularly in low and middle income countries, and may discourage healthcare facilities from investing in such advanced technologies.

Covid-19 Impact:

The COVID-19 pandemic had a mixed impact on the market. While disruptions in hospital visits and elective procedures temporarily reduced device utilization in clinical settings, the demand for remote monitoring solutions increased significantly. Patients and healthcare providers increasingly relied on wearable devices and telehealth platforms to ensure continuity of care. This shift accelerated the adoption of home-based monitoring technologies and digital health integration. Post-pandemic, the market continues to benefit from this transition toward decentralized and patient-centric care models.

The paediatric segment is expected to be the largest during the forecast period

The paediatric segment is expected to account for the largest market share during the forecast period, due to the high prevalence of epilepsy in children and the critical need for early diagnosis and continuous monitoring. Pediatric patients often require long-term observation to accurately classify seizure types and optimize treatment plans. Increasing parental awareness, improved access to pediatric neurology services and advancements in child-friendly wearable monitoring devices further supports segment growth, ensuring better disease management and improved quality of life.

The neurology centres segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the neurology centres segment is predicted to witness the highest growth rate, due to increasing specialization of epilepsy diagnosis and treatment. These centers are equipped with advanced EEG monitoring systems and skilled professionals capable of handling complex neurological cases. Growing referrals to specialized centers, along with rising investments in dedicated neurological infrastructure, are driving segment expansion. Additionally, the integration of advanced technologies such as AI-based diagnostics enhances efficiency and accuracy, further boosting demand.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to its large population base, rising prevalence of neurological disorders, and improving healthcare infrastructure. Increasing government initiatives to enhance healthcare accessibility, coupled with growing awareness of epilepsy diagnosis and treatment, are driving demand for monitoring devices. Additionally, expanding medical facilities, rising healthcare expenditure, and the presence of emerging economies such as China and India contribute significantly to regional market dominance.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to advanced healthcare systems, high adoption of innovative medical technologies, and strong presence of key market players. The region benefits from robust research and development activities, increasing investment in digital health, and widespread use of wearable monitoring devices. Furthermore, favorable reimbursement policies, growing awareness of neurological disorders, and increasing demand for remote patient monitoring solutions are accelerating market growth across the region.

Key players in the market

Some of the key players in Epilepsy Monitoring Devices Market include Natus Medical, Inc., Compumedics Limited, Nihon Kohden Corporation, Medtronic plc, Koninklijke Philips N.V., GE HealthCare, Masimo Corporation, Cadwell Industries, Inc., NeuroPace, Inc., Empatica Inc., BioSerenity, BrainScope Company, Inc., Seer Medical, Stratus and Dragerwerk AG & Co. KGaA

Key Developments:

In March 2026, Medtronic plc expanded its multiyear alliance with GE HealthCare to accelerate next-generation innovation, integrate advanced patient monitoring technologies, and enhance clinical solutions, enabling more efficient workflows, improved patient outcomes, and broader access to connected, data-driven healthcare systems globally.

In February 2026, Medtronic announced its intent to acquire CathWorks for up to $585 million, strengthening its cardiovascular portfolio. The deal builds on their 2022 partnership and integrates AI-based FFRangio technology to enhance coronary disease diagnosis and treatment, pending regulatory approval.

Products Covered:

• Conventional Devices
• Wearable Devices
• Implantable Devices
• Smart Devices

Types Covered:

• Focal Seizures
• Generalized Seizures

Distribution Channels Covered:

• Retail Sales
• Online Sales
• Direct Tenders
• Other Distribution Channels

Technologies Covered:

• Electroencephalography (EEG)
• Accelerometry
• Vagus Nerve Stimulation (VNS)
• Deep Brain Stimulation (DBS)
• Responsive Neurostimulation (RNS)

End Users Covered:

• Hospitals & Clinics
• Neurology Centres
• Diagnostic Centres
• Ambulatory Surgical Centres (ASCs)
• Homecare Settings
• Research Institutes

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Epilepsy Monitoring Devices Market, By Product

• 5.1 Conventional Devices
• 5.2 Wearable Devices
• 5.3 Implantable Devices
• 5.4 Smart Devices

6 Global Epilepsy Monitoring Devices Market, By Type

• 6.1 Focal Seizures
• 6.2 Generalized Seizures

7 Global Epilepsy Monitoring Devices Market, By Patient Type

• 7.1 Paediatric
• 7.2 Adult
• 7.3 Geriatric

8 Global Epilepsy Monitoring Devices Market, By Distribution Channel

• 8.1 Retail Sales
• 8.2 Online Sales
• 8.3 Direct Tenders
• 8.4 Other Distribution Channels

9 Global Epilepsy Monitoring Devices Market, By Technology

• 9.1 Electroencephalography (EEG)
• 9.2 Accelerometry
• 9.3 Vagus Nerve Stimulation (VNS)
• 9.4 Deep Brain Stimulation (DBS)
• 9.5 Responsive Neurostimulation (RNS)

10 Global Epilepsy Monitoring Devices Market, By End User

• 10.1 Hospitals & Clinics
• 10.2 Neurology Centres
• 10.3 Diagnostic Centres
• 10.4 Ambulatory Surgical Centres (ASCs)
• 10.5 Homecare Settings
• 10.6 Research Institutes

11 Global Epilepsy Monitoring Devices Market, By Geography

• 11.1 North America
  • 11.1.1 United States
  • 11.1.2 Canada
  • 11.1.3 Mexico
• 11.2 Europe
  • 11.2.1 United Kingdom
  • 11.2.2 Germany
  • 11.2.3 France
  • 11.2.4 Italy
  • 11.2.5 Spain
  • 11.2.6 Netherlands
  • 11.2.7 Belgium
  • 11.2.8 Sweden
  • 11.2.9 Switzerland
  • 11.2.10 Poland
  • 11.2.11 Rest of Europe
• 11.3 Asia Pacific
  • 11.3.1 China
  • 11.3.2 Japan
  • 11.3.3 India
  • 11.3.4 South Korea
  • 11.3.5 Australia
  • 11.3.6 Indonesia
  • 11.3.7 Thailand
  • 11.3.8 Malaysia
  • 11.3.9 Singapore
  • 11.3.10 Vietnam
  • 11.3.11 Rest of Asia Pacific
• 11.4 South America
  • 11.4.1 Brazil
  • 11.4.2 Argentina
  • 11.4.3 Colombia
  • 11.4.4 Chile
  • 11.4.5 Peru
  • 11.4.6 Rest of South America
• 11.5 Rest of the World (RoW)
  • 11.5.1 Middle East
    • 11.5.1.1 Saudi Arabia
    • 11.5.1.2 United Arab Emirates
    • 11.5.1.3 Qatar
    • 11.5.1.4 Israel
    • 11.5.1.5 Rest of Middle East
  • 11.5.2 Africa
    • 11.5.2.1 South Africa
    • 11.5.2.2 Egypt
    • 11.5.2.3 Morocco
    • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

• 12.1 Industry Value Network and Supply Chain Assessment
• 12.2 White-Space and Opportunity Mapping
• 12.3 Product Evolution and Market Life Cycle Analysis
• 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

• 13.1 Mergers and Acquisitions
• 13.2 Partnerships, Alliances, and Joint Ventures
• 13.3 New Product Launches and Certifications
• 13.4 Capacity Expansion and Investments
• 13.5 Other Strategic Initiatives

14 Company Profiles

• 14.1 Natus Medical, Inc.
• 14.2 Compumedics Limited
• 14.3 Nihon Kohden Corporation
• 14.4 Medtronic plc
• 14.5 Koninklijke Philips N.V.
• 14.6 GE HealthCare
• 14.7 Masimo Corporation
• 14.8 Cadwell Industries, Inc.
• 14.9 NeuroPace, Inc.
• 14.10 Empatica Inc.
• 14.11 BioSerenity
• 14.12 BrainScope Company, Inc.
• 14.13 Seer Medical
• 14.14 Stratus
• 14.15 Dragerwerk AG & Co. KGaA